Target intelligence / Profile preview

CLK3 antisense RNA 1 (CLK3-AS1)

Target
CLK3-AS1
Molecular classification
Antisense RNA, Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

CLK3 antisense RNA 1 (CLK3-AS1) is presumed to be a long non-coding RNA, transcribed from the opposite strand of the *CLK3* gene locus. Antisense RNAs like CLK3-AS1 typically regulate the expression of their corresponding sense gene (here, CDC-like kinase 3 or CLK3) through direct interaction with mRNA, influencing its splicing, stability, or translation, or by recruiting chromatin modifiers to alter gene transcription[3][4]. There is no experimental or clinical evidence available that designates CLK3-AS1 as a therapeutic target, biomarker, or disease gene; further research is needed to establish any biological or pathological roles for this molecule.\nIf this query is intended for drug discovery or clinical context, “CLK3 antisense RNA 1 (CLK3-AS1)” should not be used as a canonical drug or receptor target entry.

02

Mechanism of action

no drug interacts with CLK3-AS1; antisense RNAs generally act by RNA-RNA base pairing and gene transcription regulation[3]

03

Biological functions

Regulation of gene expression (via complementary binding to *CLK3* mRNA and possibly modulating transcription, splicing, or translation)Potential epigenetic regulation (analogy to known antisense RNAs)
04

Disease associations

Other (some antisense lncRNAs have been linked to cancer or other diseases, but no direct role for CLK3-AS1 is described)

Beyond the preview

Go deeper on CLK3 antisense RNA 1 (CLK3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLK3 antisense RNA 1 (CLK3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call